导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.09% | 1744/4773 |
| 近一周 | -2.42% | 2116/5462 |
| 近一月 | -4.05% | 2172/5421 |
| 近一季 | -4.91% | 1726/5209 |
| 近半年 | -6.89% | 3153/4920 |
| 近一年 | 8.22% | 1214/4366 |
| 近两年 | 51.25% | 1433/2954 |
| 近三年 | 24.87% | 1282/2253 |
| 成立以来 | 87.45% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.46% 1265/4961 |
7.50% 2698/5312 |
- - |
- - |
| 2025 | 17.75% 2355/4813 |
-0.77% 2402/3635 |
-0.28% 2871/4076 |
16.05% 2730/4524 |
2.53% 919/4813 |
| 2024 | 8.70% 1526/3463 |
-1.50% 1234/2808 |
-5.31% 1689/3014 |
15.01% 1842/3129 |
1.34% 1081/3463 |
| 2023 | 5.20% 198/2656 |
11.27% 344/2280 |
-0.94% 430/2385 |
-1.01% 476/2515 |
-3.58% 730/2655 |
| 2022 | -11.77% 256/2207 |
-8.07% 269/1919 |
-0.51% 1630/2016 |
-7.85% 149/2113 |
4.68% 525/2208 |
| 2021 | 23.02% 133/1822 |
3.04% 201/1255 |
7.09% 701/1330 |
9.79% 130/1466 |
1.55% 884/1822 |
| 2020 | 21.20% 693/1250 |
-3.67% 315/1028 |
12.56% 682/1067 |
9.83% 612/1164 |
1.77% 1018/1184 |
| 2019 | 23.07% 636/1092 |
29.99% 263/739 |
-8.61% 600/788 |
-0.68% 607/850 |
4.30% 813/918 |
| 2018 | -24.13% 318/834 |
- - |
-13.79% 461/631 |
-3.56% 328/660 |
-6.59% 49/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 景顺长城中证500行业中性低波动指数A VS. 长安沪深300非周期A(740101) |